Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
Titel:
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
Auteur:
Angioni, D. Hansson, O. Bateman, R. J. Rabe, C. Toloue, M. Braunstein, J. B. Agus, S. Sims, J. R. Bittner, T. Carrillo, M. C. Fillit, H. Masters, C. L. Salloway, S. Aisen, P. Weiner, M. Vellas, B. Gauthier, S. , Abushakra, Susan Afshar, Mohammad Alam, John Algeciras-Schimnich, Alicia Andrieu, Sandrine Ballard, Clive Baruch, Amos Batrla, Richard Baudler, Monika Bell, Joanne Bozeat, Sasha Brooks, Dawn Brooks, Tricia Bullain, Szofia Burmeister, Jan Cho, Min Collins, Emily Cook, Gavin Cummings, Jeffrey Dague, Chris De Santi, Susan Doody, Rachelle Dunn, Billy Egan, Michael Eriksson, Sven Esquivel, Rianne Fagan, Tom Ferrell, Phyllis Gallagher, Michela Grönblad, Anna-Kaija Hains, Avis Hampel, Harald Hefting, Nanco Hendrix, Suzanne Ho, Carole Hu, Helen Ismail, Zahinoor Jones, Daryl Kinney, Gene Kinnon, Paul Kurzman, Ricky Lannfelt, Lars Lawson, John LeBastard, Nathalie Legrand, Valérie Lewandowski, Nicole Lim, Carine Lyketsos, Costantine Masterman, Donna Lu, Ming Mintun, Mark Molinuevo, José Luis Monteiro, Cecilia Navia, Bradford Odergren, Tomas Osswald, Gunilla Penny, Lewis Pontecorvo, Michael Porsteinsson, Anton Raman, Rema Respondek, Gesine Reyderman, Larisa Rogers, Sharon Rosenberg, Paul Rosenzweig-Lipson, Sharon Roskey, Mark Carrie, Rubel Saad, Ziad Schindler, Rachel Selkoe, Dennis Shulman, Melanie Sink, Kaycee Sipe, Lisa Skovronsky, Daniel Somers, Elizabeth Soto, Maria Streffer, Johannes Such, Pedro Suhy, Joyce Touchon, Jacques Vandijck, Manu White, Anne Wilson, David Zago, Wagner Zhou, Jin